| Cas No.: | 1202757-89-8 |
| 名称: | |
| 别名: | CC-292; AVL292; AVL-292; AVL 292 |
| SMILES: | COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F |
| 分子式: | C22H22FN5O3 |
| 分子量: | 423.44 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | AVL-292, also known as CC-292, is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL-292 targets and covalently binds to BTK, thereby prevent |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |




